Page last updated: 2024-09-03

way 123398 and clofilium

way 123398 has been researched along with clofilium in 2 studies

Compound Research Comparison

Studies (way 123398)	Trials (way 123398)	Recent Studies (post-2010) (way 123398)	Studies (clofilium)	Trials (clofilium)	Recent Studies (post-2010) (clofilium)
15	0	1	140	1	21

Protein Interaction Comparison

Protein	Taxonomy	way 123398 (IC50)	clofilium (IC50)
Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)		0.0813

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Finlayson, K; Kelly, JS; Pennington, AJ	1
Finlayson, K; January, CT; Kelly, JS; Sharkey, J; Turnbull, L	1

Other Studies

2 other study(ies) available for way 123398 and clofilium

Article	Year
[3H]dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel? European journal of pharmacology, 2001, Feb-02, Volume: 412, Issue:3 Topics: Animals; Anti-Arrhythmia Agents; Benzimidazoles; Binding Sites; Cation Transport Proteins; Cell Line; DNA-Binding Proteins; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Membrane Potentials; Patch-Clamp Techniques; Phenethylamines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Binding; Quaternary Ammonium Compounds; Radioligand Assay; RNA; Sulfanilamides; Sulfonamides; Trans-Activators; Transcriptional Regulator ERG; Tumor Cells, Cultured	2001
[3H]dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. European journal of pharmacology, 2001, Oct-26, Volume: 430, Issue:1 Topics: Anti-Arrhythmia Agents; Benzimidazoles; Binding, Competitive; Cation Transport Proteins; Cell Line; Cell Membrane; DNA-Binding Proteins; Drug Evaluation, Preclinical; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Haloperidol; Humans; Patch-Clamp Techniques; Phenethylamines; Pimozide; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quaternary Ammonium Compounds; Sulfanilamides; Sulfonamides; Terfenadine; Trans-Activators; Transcriptional Regulator ERG; Transfection; Tritium	2001

Article

Year

[3H]dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel?

European journal of pharmacology, 2001, Feb-02, Volume: 412, Issue:3

Topics: Animals; Anti-Arrhythmia Agents; Benzimidazoles; Binding Sites; Cation Transport Proteins; Cell Line; DNA-Binding Proteins; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Membrane Potentials; Patch-Clamp Techniques; Phenethylamines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Binding; Quaternary Ammonium Compounds; Radioligand Assay; RNA; Sulfanilamides; Sulfonamides; Trans-Activators; Transcriptional Regulator ERG; Tumor Cells, Cultured

2001

[3H]dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen.

European journal of pharmacology, 2001, Oct-26, Volume: 430, Issue:1

Topics: Anti-Arrhythmia Agents; Benzimidazoles; Binding, Competitive; Cation Transport Proteins; Cell Line; Cell Membrane; DNA-Binding Proteins; Drug Evaluation, Preclinical; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Haloperidol; Humans; Patch-Clamp Techniques; Phenethylamines; Pimozide; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quaternary Ammonium Compounds; Sulfanilamides; Sulfonamides; Terfenadine; Trans-Activators; Transcriptional Regulator ERG; Transfection; Tritium

2001